Agilent Technologies, Inc. (A)
Sector: Technology
Industry: Laboratory Analytical Instruments
Country: United States
Exchange: NYSE
Market cap: $44.08B
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Latest financial period: July 31, 2026
Filed with the SEC: September 1, 2026
Estimated earnings date: Not available
Profit #409 of 1484 companies
| | Jul 26 | Apr 26 | Jan 26 | Oct 25 |
|---|
| ROIC | 16.2% | 16.3% | 16.3% | 16.6% |
Growth #845 of 1484 companies
Payout #119 of 1484 companies
Safety #201 of 1484 companies
Price #970 of 1484 companies
